Harnessing Gene Expression in Ewing Sarcoma: How to Increase the Therapeutic Opportunities
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 136
Special Issue Editor
Interests: RNA biology; transcriptomics; alternative splicing; drug–DNA interactions; inflammation; cancer biology; pancreatic cancer; pancreatitis; gastroenterology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ewing sarcoma is a highly aggressive bone and soft tissue tumor that primarily affects children and young adults. Despite advancements in treatment, the prognosis for patients with metastatic or recurrent Ewing sarcoma remains poor. Therefore, there is a critical need to explore novel therapeutic strategies to improve outcomes for these patients. Harnessing gene expression in Ewing sarcoma represents a promising approach to increase therapeutic opportunities and enhance treatment efficacy.
We look forward to receiving your contributions.
Dr. Hassan Mubarak Ishqi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene expression
- Ewing sarcoma
- therapy
- molecular targets
- bone and soft tissue tumor
